Silvia Ortega-Gutiérrez

12PUBLICATIONS
31CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsBiologically active moleculesTraditional, complementary and integrative medicine not elsewhere classifiedMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 13, 2026
ICMT supports BRAFV600E-driven tumor growth by membrane targeting of the CAAX protein INPP5E.

|Mar 23, 2026
First Generation Proteolysis Targeting Chimeras (PROTACs) for the Treatment of Progeria.

Jon Macicior-Michelena, Marcelino Telechea, Daniel Fernández

|Apr 28, 2023
New Pharmacological Approaches for Rare Diseases.

Silvia Ortega-Gutiérrez

|Aug 26, 2022
New Trends in Aging Drug Discovery.

Bellinda Benhamú, Mar Martín-Fontecha, Henar Vázquez-Villa

|Aug 10, 2022
Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA2), UCM-14216, Ameliorates Spinal Cord Injury in Mice.

Nora Khiar-Fernández, Debora Zian, Henar Vázquez-Villa

Pageof 2